Better medicines for children: EU Commission initiative to get best and safest treatments for children Part 3

We've removed all the common verbs from this article, try and put them back correctly.

Better medicines for children: EU Commission initiative to get best and safest treatments for children Part 3 (Teacher: Michael)

It is also suggested that specific research funding allocated in combination with a mechanism to ensure that it is dedicated to priority areas for the health of European children.

Medicines specifically designed for children limited to traditional areas, among which routine childhood infections and vaccines to to prevent some serious childhood diseases. Very few treatments, for example, designed or adapted to treat children with diseases such as cancer, AIDS or cardiac disorders.

Doctors trying to adapt adult treatments to children often a tough dilemma, the EU paper called " Medicines for Children". Children, and especially toddlers, not just small adults. Inadequate dosing information, or calculation errors in adjusting the dose raise the risks of adverse reactions (overdose) or ineffective treatment (underdose). However careful the calculation, the child's metabolism differs from that of an adult, and this affect the way a particular medicine works.

What is needed not ad hoc dosing decisions but child-specific designs and testing. Failure to provide this lead to a denial of the benefits of therapeutic progress.

The absence of suitable authorised medicinal products to treat diseases in children which both tested and assessed is an issue that of concern for some time, the EU Commission's consultation paper. Individual EU member states, regulators, paediatricians and parents raised the subject in various fora.

Read the article